Prihlásiť sa Zaregistrujte sa zadarmo

EBITDA spoločnosti Shenzhen Chipscreen Biosciences Co

Aká je hodnota metriky EBITDA spoločnosti Shenzhen Chipscreen Biosciences Co?

Hodnota metriky EBITDA spoločnosti Shenzhen Chipscreen Biosciences Co., Ltd. je ¥299.772k

Aká je definícia metriky EBITDA?



EBITDA je zisk pred odpočítaním úrokov, daní, odpisov, a amortizácie reprezentujúci operačnú výkonnosť spoločnosti.

Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.

EBITDA spoločností v sektore Health Care sektor na SSE v porovnaní so spoločnosťou Shenzhen Chipscreen Biosciences Co

Čomu sa venuje spoločnosť Shenzhen Chipscreen Biosciences Co?

Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs. The company develops precursor compounds and original new drug product lines that are in various research phase of the specific global intellectual property protection in three areas, such as cancer, metabolic diseases, and autoimmune diseases. Shenzhen Chipscreen Biosciences Co., Ltd. was founded in 2001 and is based in Shenzhen, China.

Firmy s metrikou ebitda podobnou spoločnosti Shenzhen Chipscreen Biosciences Co